AmphetamineAmphetaminesCentral Nervous System StimulantsDextroamphetamineAmphetamine-Related DisordersMethamphetamineBipolar DisorderMental DisordersSubstance Abuse DetectionAnxiety DisordersMood DisordersN-Methyl-3,4-methylenedioxyamphetamineDopamineStereotyped BehaviorAttention Deficit Disorder with HyperactivityDiagnostic and Statistical Manual of Mental Disorders3,4-MethylenedioxyamphetamineMotor ActivitySubstance-Related DisordersNucleus AccumbensDopamine AgentsBehavior, AnimalGas Chromatography-Mass SpectrometryStreet DrugsDopamine Uptake InhibitorsDepressive Disorder, MajorDesigner DrugsAppetite DepressantsCocaineDopamine Plasma Membrane Transport ProteinsRats, Sprague-DawleyDepressive DisorderCorpus StriatumObsessive-Compulsive DisorderMethylphenidateStress Disorders, Post-TraumaticAutistic DisorderPsychotic DisordersPhobic DisordersChild Development Disorders, PervasiveHallucinogensDose-Response Relationship, DrugAdrenergic Uptake InhibitorsEnzyme Multiplied Immunoassay TechniqueForensic MedicineDopamine AgonistsBrainNeostriatump-ChloroamphetamineReceptors, Dopamine D2Dopamine AntagonistsPsychoses, Substance-InducedPsychotropic DrugsConduct DisorderMicrodialysisMethyltyrosinesPhenmetrazineNomifensinePsychiatric Status Rating ScalesHyperkinesisTic DisordersPyrazolonesEphedrineConditioning, OperantFenfluramineSubstance Withdrawal SyndromeAnalysis of VarianceCaudate NucleusBenzphetamineTime FactorsCognition DisordersSerotoninBorderline Personality DisorderSerotonin AgentsRewardStartle ReactionMovement DisordersSomatoform DisordersDrug InteractionsVentral Tegmental Areaalpha-MethyltyrosineSleep DisordersApomorphinePhenethylaminesNarcolepsyCocaine-Related DisordersReceptors, Biogenic AmineRats, Long-EvansComorbidityRacloprideSelf AdministrationAdrenergic AgentsExploratory BehaviorPhenylpropanolamineHairBarbituratesPrefrontal CortexLymphoproliferative DisordersReceptors, DopamineLocomotion